Insulet (PODD) Revenue — Quarter Ended Mar 31, 2023
Revenue for the quarter decreased compared to the preceding quarter but rose substantially versus the same period a year ago. The trailing twelve-month revenue reached a noteworthy level.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Revenue for the quarter decreased compared to the preceding quarter but rose substantially versus the same period a year ago. The trailing twelve-month revenue reached a noteworthy level.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$358.1M
Revenue reported for this quarter.
Quarter-over-quarter
-3.1%
Change from the immediately preceding quarter.
Year-over-year
+45.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $299.4M | +15.2% |
| Sep 30, 2022 | $340.8M | +30.2% |
| Dec 31, 2022 | $369.7M | +13.1% |
| Mar 31, 2023 | $358.1M | +45.0% |
Revenue performance
Quarterly revenue experienced a mild decline from the prior quarter, while the year-over-year comparison showed a strong increase.
Quarterly comparison
Compared to the immediately preceding quarter, revenue contracted slightly. However, it was much higher than in the same quarter of the previous year.
What to watch
Monitor whether the company can maintain its year-over-year revenue growth trajectory.